Product Launch (Blog)

Jun, 21 2023

Unleashing the Power of Vaccines for a Disease-Free World

The global increase in reported COVID-19 cases created widespread anticipation for a vaccine capable of combating the virus. This heightened demand for coronavirus vaccines is expected to drive the development of the vaccine market. Governments and medical regulators expedited the vaccine development process due to the severity of the epidemic, despite the typically lengthy testing requirements for vaccines. This accelerated approach aimed to address the urgent need for an effective solution to control the spread of the virus.

According to Data Bridge Market Research, the Global Vaccines Market is USD 67.57 billion in 2022, is expected to reach USD 152.39 billion by 2030, at a CAGR of 10.7% during the forecast period 2023 to 2030.

“Technological advancements in vaccine administration surge market growth"

The main driving force behind modern vaccination technologies is the desire to speed up the time it takes to respond to emerging threats and make vaccines easily accessible for quick deployment. Innovation in the vaccines industry is also focused on the creation of vaccines that are effective against difficult targets and the advancement of delivery methods for maximum potency. New developments in vaccine delivery technology include the development of synthetic vaccine candidates, genetic studies of disease progression and vaccine response, structure-based antigen design, and nanoparticle delivery techniques.

What restraints the growth of the global vaccines market?

“Regulatory Challenges will hinder the growth”

Regulatory challenges in the vaccine market arise from the rigorous processes involved in vaccine development and regulatory approval. Vaccine manufacturers must meet stringent requirements, conduct extensive clinical trials, and demonstrate safety and efficacy before gaining regulatory approval. These processes can be time-consuming and costly, posing barriers for manufacturers, particularly smaller ones. The stringent regulatory landscape can slow down market growth by increasing the time and resources required to bring new vaccines to market.

 Segmentation: Global Vaccines Market  

The vaccines market is segmented on the basis of composition, type, kind, age of administration, diseases, route of administration, end user, and distribution channel.

  • On the basis of composition, the vaccines market is segmented into combination vaccines, monovaccines.
  • On the basis of type, the vaccines market is segmented into subunit, recombinant, polysaccharide, and conjugate vaccines, live-attenuated vaccines, inactivated vaccines, toxoid vaccines, dna vaccines.
  • On the basis of kind, the vaccines market is segmented into routine vaccine, recommended vaccine, required vaccine.
  • On the basis of age of administration, the vaccines market is segmented into pediatric vaccine, adult vaccine.
  • On the basis of diseases, the vaccines market is segmented into pneumococcal disease, measles, mumps and varicella, dpt, hepatitis, influenza, typhoid, meningococcal, rabies, japanese encephalitis, yellow fever, others.
  • On the basis of route of administration, the vaccines market is segmented into injectable, oral, nasal.
  • On the basis of end user, the vaccines market is segmented into community hospitals, hospitals, specialty centres, clinics, and others.
  • On the basis of distribution channel, the vaccines market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy.

Regional Insights: North America dominates the Global Vaccines Market  

North America dominates the vaccine market owing to several significant companies and cutting-edge healthcare infrastructure. Rotavirus, pneumococcal conjugate, and human papillomavirus vaccines are just a few of the new vaccines being developed today. These vaccines promise to open up new opportunities for cost savings, as well as for creating new supply chains and distribution logistics.

Asia-Pacific is expected to grow at the highest rate in the forecast period of owing to the expanding patient population, increasing industry investment, and government support.

To know more about the study, visit,

Recent Developments in Global Vaccines Market  

  • In 2021, For its experimental vaccine PRIORIX, GlaxoSmithKline plc announced that it had submitted a Biologics License Application (BLA) to the USFDA. The vaccine, which was initially registered in Germany, has recently received authorization from more than 100 nations.
  • In 2020, Two subsidiaries of Mitsubishi Tanabe Pharma Corporation, GlaxoSmithKline plc and Medicago Inc., announced their partnership. To develop a plant-based virus-like particle (VLP) vaccine for COVID-19, they formed a partnership.

 The Prominent Key Players Operating in the Global Vaccines Market Include:

  • Merck & Co., Inc. (U.S.)
  • Pfizer Inc. (U.S.)
  • GSK plc (U.K.)
  • Sanofi (France)
  • Serum Institute of India Pvt. Ltd. (India)
  • AstraZeneca (U.K.)
  • Johnson & Johnson Private Limited (U.S.)
  • Indian Immunologicals Ltd. (India)
  • Novasep (France)
  • MerckKGaA (Germany)
  • Charles River Laboratories (U.K.)
  • uniQure N.V. (Netherlands)
  • Waisman Biomanufacturing (U.S.)
  • Creative-Biogene (U.S.)
  • Aldevron (U.S.)
  • Addgene (U.S.)
  • Oxford Biomedica (U.K.)
  • Thermo Fisher Scientific (U.S.)
  • Fujifilm Corporation (Japan)
  • Spark Therapeutics Inc. (U.S.)

Above are the key players covered in the report, to know about more and exhaustive list of global vaccines market   companies contact,

Research Methodology: Global Vaccines Market  

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by dbmr research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, global vs regional and vendor share analysis. Please request analyst call in case of further inquiry.

Client Testimonials